格隆汇1月14日丨久远银海(002777.SZ)公布，近日，全国高新技术企业认定管理工作领导小组办公室发 布了《对四川省认定机构2025年认定报备的第四批高新技术企业进行备案的公告》《对浙江省认定机构 2025年认定报备高新技术企业进行备案的公告》，根据备案名单，四川久远银海软件股份有限公司控股 子公司四川兴政信息技术有限公司（简称"四川兴政公司"）、杭州海量信息技术有限公司（简称"杭州 海量公司"）通过了高新技术企业的认定。四川兴政公司高新技术企业证书编号为：GR202551004038， 发证日期：2025年12月8日，有效期三年。杭州海量公司高新技术企业证书编号为：GR202533003725， 发证日期：2025年12月19日，有效期三年。四川兴政公司、杭州海量公司通过本次高新技术企业的认定 系原证书有效期满后进行的重新认定。 ...

证券代码：002777 证券简称：久远银海 公告编号：2026-002 四川久远银海软件股份有限公司 关于控股子公司通过高新技术企业重新认定的公告 近日，全国高新技术企业认定管理工作领导小组办公室发布了《对四川省认定机构 2025 年认定报备的第四批高新技术企业进行备案的公告》《对浙江省认定机构 2025 年认定报备高 新技术企业进行备案的公告》，根据备案名单，四川久远银海软件股份有限公司（以下简称"公 司"）控股子公司四川兴政信息技术有限公司（以下简称"四川兴政公司"）、杭州海量信息 技术有限公司（以下简称"杭州海量公司"）通过了高新技术企业的认定。 四川兴政公司高新技术企业证书编号为：GR202551004038，发证日期：2025 年 12 月 8 日， 有效期三年。 杭州海量公司高新技术企业证书编号为：GR202533003725，发证日期：2025 年 12 月 19 日，有效期三年。 四川兴政公司、杭州海量公司通过本次高新技术企业的认定系原证书有效期满后进行的重 新认定。根据国家对高新技术企业税收优惠政策的相关规定，四川兴政公司、杭州海量公司自 通过高新技术企业认定后，可连续三年（2025 年度至 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002777 证券简称：久远银海 公告编号：2026-001 四川久远银海软件股份有限公司 四川久远银海软件股份有限公司（以下简称"公司"）全资子公司四川久远银海畅辉软件有限公司（以下 简称"畅辉软件公司"）因经营需要，于近日完成了注册地址变更的工商登记手续，并取得了由绵阳市涪 城区政务服务和行政审批局换发的《营业执照》；公司控股子公司杭州海量信息技术有限公司（以下简 称"杭州海量公司"）因经营需要，于近日完成了注册地址变更的工商登记手续，并取得了由杭州市西湖 区市场监督管理局换发的《营业执照》。 上述两家子公司本次工商登记变更除注册地址变更外，其他登记事项未发生变更。现将有关变更情况公 告如下： ■ 二、备查文件 1、变更后的畅辉软件公司《营业执照》； 2、变更后的杭州海量公司《营业执照》。 特此公告。 四川久远银海软件股份有限公司董事会 关于全资及控股子公司完成注册地址变更的公告 二〇二六年一月十四日 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、基本情况 ...

证券代码：002777 证券简称：久远银海 公告编号：2026-001 上述两家子公司本次工商登记变更除注册地址变更外，其他登记事项未发生变更。现将有 关变更情况公告如下： | 子公司名称 | 变更事项 | 变更前 | | | | | 变更后 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 四川久远银海 | 住所 | 绵阳市涪城区九州大道 303 | | 号 | | | 四川省绵阳市涪城区绵安路35 | | | | 畅辉软件有限 | | | | | 号 B | 区 | 319-326、333 | 室 | | | 公司 | | | | | | | | | | | 杭州海量信息 | 住所 | 浙江省杭州市西湖区古天巷 | | 8 | | | 浙江省杭州市西湖区古荡街道 | | | | 技术有限公司 | | 号古荆商务中心 1 号楼 13 | | 楼 | 古天巷 | 8 | | 1 号 | 号古荆商务中心 | | | | 1301、1303、1304 | 室 | | 楼 11 | 楼 | 1106 室 | | | 二、备查文 ...

Group 1 - The stock price of Jiuyuan Yinhai has increased by 5.75% to 22.99 CNY per share, with a trading volume of 744 million CNY and a turnover rate of 8.45%, resulting in a total market capitalization of 9.385 billion CNY [1] - Jiuyuan Yinhai has experienced a continuous increase in stock price for three consecutive days, with a cumulative increase of 19.45% during this period [1] - The company, established on November 24, 2008, and listed on December 31, 2015, focuses on software products, operation and maintenance services, and system integration in the field of social security and human resources [1] Group 2 - The fund managed by Huatai-PineBridge has a significant holding in Jiuyuan Yinhai, with the Huatai-PineBridge CSI Internet Medical Index (LOF) A (501007) reducing its holdings by 32,380 shares to 423,600 shares, representing 4.89% of the fund's net value [2] - The fund has realized a floating profit of approximately 529,500 CNY today and a total floating profit of 1.4996 million CNY during the three-day stock price increase [2] - The Huatai-PineBridge CSI Internet Medical Index (LOF) A (501007) was established on December 22, 2016, with a current scale of 70.2192 million CNY and a year-to-date return of 14.69%, ranking 327 out of 5,517 in its category [2]

1月12日，久远银海涨5.17%，截至发稿，报21.36元/股，成交6427.44万元，换手率0.74%，总市值87.20 亿元。 资料显示，四川久远银海软件股份有限公司位于四川省成都市三色路163号，成立日期2008年11月24 日，上市日期2015年12月31日，公司主营业务涉及以人力资源和社会保障为核心的民生信息化领域软件 产品、运维服务和系统集成。主营业务收入构成为：运维服务49.40%，软件34.76%，系统集成 15.60%，其他(补充)0.24%。 南方中证1000ETF（512100）基金经理为崔蕾。 截至发稿，崔蕾累计任职时间7年68天，现任基金资产总规模1227.6亿元，任职期间最佳基金回报 234.52%， 任职期间最差基金回报-15.93%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 从久远银海十大流通股东角度 数据显示，南方基金旗下1只基金位居久远银海十大流通股东。南方中证1000ETF（512100）三季度减 持1.6 ...

Group 1 - The family doctor concept index rose by 4.40%, ranking 10th among concept sectors, with 25 stocks increasing in value, including Meinian Health, Jiuyuan Yinhai, and Guoxin Health reaching the daily limit [1] - Notable gainers in the family doctor sector included Weining Health, which increased by 13.79%, Jiao Dian Technology by 9.43%, and Chuangye Huikang by 9.28% [1] - The sector experienced a net outflow of 1.975 billion yuan, with 13 stocks seeing net inflows, and 5 stocks receiving over 100 million yuan in net inflows, led by Keda Xunfei with a net inflow of 536 million yuan [2][3] Group 2 - The top stocks by net inflow ratio in the family doctor concept were Meinian Health at 43.26%, Guoxin Health at 42.77%, and Jiuyuan Yinhai at 24.29% [3] - The family doctor concept's top stocks included Keda Xunfei with a 4.10% increase and a turnover rate of 6.48%, Meinian Health with a 10.05% increase and a turnover rate of 4.37%, and Jiuyuan Yinhai with a 10.02% increase and a turnover rate of 10.61% [3][4] - Other notable stocks included Jiao Dian Technology with a 9.43% increase and a turnover rate of 11.13%, and Guoxin Health with a 10.01% increase and a turnover rate of 2.90% [4]

Core Viewpoint - The DRG/DIP concept has seen a significant increase of 5.67%, ranking third among concept sectors, with 21 stocks rising, including a 20% surge in Di'an Diagnostics, and several other stocks reaching their daily limit up [1][2]. Group 1: Market Performance - The DRG/DIP concept sector experienced a net inflow of 350 million yuan, with 14 stocks receiving net inflows, and 7 stocks attracting over 30 million yuan each [2]. - Di'an Diagnostics led the net inflow with 290 million yuan, followed by Jiuyuan Yinhai and Guoxin Health with net inflows of 206 million yuan and 127 million yuan, respectively [2][3]. Group 2: Stock Performance - The top performers in the DRG/DIP concept included: - Di'an Diagnostics with a 20% increase and a turnover rate of 20.80% [3]. - Jiuyuan Yinhai with a 10.02% increase and a turnover rate of 10.61% [3]. - Guoxin Health with a 10.01% increase and a turnover rate of 2.90% [3]. - Other notable stocks include: - Weining Health with a 13.79% increase and a turnover rate of 18.16% [4]. - Jiahe Meikang with an 11.17% increase and a turnover rate of 13.98% [3].

Core Viewpoint - The A-share market showed strong performance with the Shanghai Composite Index surpassing 4100 points, indicating a potential bullish trend in the market [3][11]. Market Performance - The Shanghai Composite Index rose by 0.92% to close at 4120.43, the Shenzhen Component Index increased by 1.15% to 14120.15, the ChiNext Index gained 0.77% to 3327.81, and the Sci-Tech Innovation Board Index surged by 2.09% to 1803.40 [4][3]. - The total trading volume in the Shanghai and Shenzhen markets reached 3.12 trillion yuan, an increase of 322.4 billion yuan compared to the previous trading day, with over 3900 stocks rising and more than a hundred stocks hitting the daily limit for two consecutive days [8]. Sector Performance - AI application themes surged, particularly in the fields of healthcare, film, and short drama games, with stocks like Meian Health, Jiuyuan Yinhai, and Guoxin Health hitting the daily limit [5][6]. - The concept of controllable nuclear fusion continued to perform strongly, with stocks such as Hongxun Technology and Xiamen Tungsten rising by the daily limit [7]. Fund Flow - Major funds saw net inflows in sectors such as non-ferrous metals, media, and home appliances, while there were net outflows in semiconductor, insurance, and electronic components sectors [10]. - Specific stocks that attracted significant net inflows included Liou Co., Jinfa Technology, and Kunlun Wanwei, with inflows of 1.747 billion yuan, 1.663 billion yuan, and 1.369 billion yuan respectively [10]. Institutional Insights - Dexun Securities noted that the Shanghai Composite Index's rise above 4100 points, coupled with increased trading volume, suggests the potential for a comprehensive bull market [11]. - Guojin Securities emphasized the acceleration of the spring market and the importance of AI chain rotation opportunities, while Xiangcai Securities highlighted the recent upward breakout of the Shanghai Composite Index, indicating a possible recovery of the upward trend from the second half of 2025 [13].

Core Viewpoint - JiuYuan YinHai (SZ002777) reached its daily limit on January 9, 2026, with a price of 20.31 yuan, marking a 10.02% increase, and a total market capitalization of 8.291 billion yuan [1] Group 1: Financial Performance - The company completed fundraising project adjustments, permanently supplementing 158 million yuan to its working capital, significantly improving capital efficiency [2] - In Q3 2025, the net profit attributable to shareholders increased by 151.66% year-on-year, while the non-recurring net profit surged by 492.73%, and the net cash flow from operating activities turned positive, improving by 131.24% year-on-year [2] Group 2: Strategic Focus - JiuYuan YinHai is focusing on three strategic directions: healthcare insurance, digital governance, and smart cities, leveraging big data and cloud computing technologies to empower the livelihood sector [2] - The current market shows high interest in digital economy and healthcare informationization, indicating potential growth in the industry [2] Group 3: Research and Development - The company's R&D investment increased by 48.69% year-on-year, indicating a stronger commitment to technological innovation, which will enhance core competitiveness [2] - Two subsidiaries received recognition as high-tech enterprises, allowing them to enjoy a 15% corporate income tax reduction for the next three years, which will improve overall profitability [2] Group 4: Market Dynamics - Technical analysis suggests that if the MACD indicator forms a golden cross and the stock price breaks through significant resistance levels, market confidence in the stock will increase [2] - On the day of the price surge, if there is significant inflow of institutional funds and high net buying amounts, it will drive the stock price up to the limit [2]